Evaxion Biotech AS (EVAX)
3.95
+0.06
(+1.54%)
USD |
NASDAQ |
May 03, 16:00
3.95
0.00 (0.00%)
After-Hours: 20:00
Evaxion Biotech Total Long Term Debt (Quarterly): 8.648M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.648M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
8.648M
Minimum
Dec 2023
8.648M
Maximum
Dec 2023
8.648M
Average
8.648M
Median
Dec 2023
Total Long Term Debt (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Ascendis Pharma A/S | 722.47M |
| Cellectis SA | 33.61M |
| Adaptimmune Therapeutics PLC | 0.00 |
| Akari Therapeutics PLC | -- |